M&A Deal Summary |
|
|---|---|
| Date | 2006-06-26 |
| Target | Pfizer Consumer Healthcare |
| Sector | Life Science |
| Buyer(s) | Johnson & Johnson |
| Sellers(s) | Pfizer |
| Deal Type | Divestiture |
| Deal Value | 16.6B USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1886 |
| Sector | Consumer Products |
| Employees | 132,000 |
| Revenue | 88.8B USD (2024) |
Johnson & Johnson is a global healthcare conglomerate that operates across three primary sectors: Pharmaceuticals, Medical Devices, and Consumer Health. In Pharmaceuticals, it develops treatments for a variety of conditions, including immunology, oncology, and infectious diseases. The Medical Devices segment offers a range of equipment and devices for healthcare professionals, encompassing orthopedics, surgery, and cardiovascular care. Its Consumer Health division markets a wide array of products, spanning baby care, oral care, skin care, over-the-counter drugs, and women's health, with popular brands such as Band-Aid, Tylenol, and Neutrogena under its umbrella. Johnson & Johnson was formed in 1886 and is based in New Brunswick, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 16 of 47 |
| Sector: Life Science M&A | 4 of 20 |
| Type: Divestiture M&A Deals | 3 of 4 |
| Country: Germany M&A | 1 of 1 |
| Year: 2006 M&A | 2 of 3 |
| Size (of disclosed) | 4 of 31 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-02-02 |
FMS Future Medical System S.A.
Geneva, Switzerland FMS Future Medical System S.A. manufactures and markets arthroscopic fluid management systems. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-11-16 |
Conor Medsystems
Menlo Park, California, United States Conor Medsystems, Inc.developed stents and other medical devices as platforms for controlled local and systemic delivery of a wide variety of therapeutic agents. The Company's initial focus was on drug-eluting stents for the treatment of restenosis and vascular disease. |
Buy | $1.4B |
| Category | Company |
|---|---|
| Founded | 1849 |
| Sector | Life Science |
| Employees | 81,000 |
| Revenue | 63.6B USD (2024) |
Pfizer is a global pharmaceutical company that is involved in the discovery, development, manufacture, and marketing of a wide range of healthcare products, including medicines and vaccines. The company's portfolio includes treatments across a broad spectrum of areas such as oncology, cardiology, neurology, and infectious diseases, among others. Pfizer was founded in 1849 and is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 19 |
| Sector: Life Science M&A | 2 of 14 |
| Type: Divestiture M&A Deals | 5 of 15 |
| Country: Germany M&A | 2 of 2 |
| Year: 2006 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 10 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-04-06 |
Rinat Neuroscience
Palo Alto, California, United States Rinat Neuroscience Corp. a biotechnology company that is developing therapeutic proteins for the treatment of diseases and disorders of the central nervous system. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-02-09 |
BioRexis Pharmaceuticals
King of Prussia, Pennsylvania, United States BioRexis Pharmaceuticals Corp. is a bio-pharmaceutical company produces biopharmaceuticals. |
Buy | - |
